Contact Us
Global

Organoid-based Drug Development platform

Accurate Prediction, Efficient Screening, Risk Control, Cost Saving

ACCURATE’s abundant organoid models and solid technological platform enhance drug discovery and development. Our organoid-based drug R&D platform covers the whole process from early drug discovery to pre-clinical and co-clinical studies, and provide on-stop solution for in vitro and ex vivo research.

Organoid Models

Tumor Organoids

1)Gastrointestinal cancer: Esophageal cancer, Gastric cancer, Pancreatic cancer, Liver cancer, Gallbladder cancer, Colorectal cancer, Anal cancer
2)Lung cancer: Adenocarcinoma, Squamous cell carcinoma, Small cell lung cancer
3)Head and neck cancer: Nasopharyngeal carcinoma, Oral cancer, Oropharyngeal cancer, Hypopharyngeal cancer, Laryngeal cancer
4)Breast cancer
5)Brain tumor: Glioma, Pituitary tumor, Craniopharyngioma, Meloblastoma, Neuroblastoma, Cerebral lymphoma
6)Gynecologic cance: Cervical cancer, Ovarian cancer, Endometrial cancer
7)Genitourinary cancer: Kidney cancer, Bladder cancer, Prostate cancer

Tumor Organoids

Non-tumor Disease Organoids

1)Pulmonary fibrosis
2)Non-alcoholic hepatitis

Non-tumor Disease Organoids

Normal Tissue Organoids

1)Liver organoid
2)Nasal mucosa organoid
3)Airway organoid
4)Bronchoalveolar organoid
5)Small intestine organoid

Normal Tissue Organoids

Organoid-based Drug Development Platform

Organoid-based Drug Screening and Pharmacodynamic Studies

Based on the comprehensive tumor organoid series model, it can provide tumor organoid drug screening, preclinical studies, Phase 0 clinical studies, indication expansion studies, etc.

Organoid-based Drug Screening and Pharmacodynamic Studies

Tumor Organoid Immune Cell Co-culture Platform

Based on the co-culture system of tumor organoids and immune cells, the tumor immune microenvironment was reconstructed in vitro to provide immunotherapy and cellular therapy related drug test and research.

Tumor Organoid Immune Cell Co-culture Platform

Organoid-based Safety Evaluation Platform

Using human liver and bile duct organoid model to provide hepatotoxicity evaluation, and study drug safety and toxicology with human models.

Organoid-based Safety Evaluation Platform

AOD

ACCURATE Organoid Database

ENTER

Academic Background

Provincial organoid research center, authoritative expert team, participate in the development of industry standards.

Solid Clinical Cohort Studies

A solid data background of tens thousands of organoid drug sensitivity test and clinical follow-up, real-world studies of marketed drugs.

Deep Learning-based Analysis System

The world's leading label-free organoid imaging analysis system for quality control and drug sensitivity analysis.

Strict QC for High Quality Data

Strict quality control system and standardized management.

Applications

01

Organoid-based High Throughput Screening

02

Preclinical Studies of Phamarcodynamics

03

Safety Evaluations

04

Investigation for New Indications

05

Phase 0 Clinical Trial

Message Board
Please select the type of service
attachment(Each file size limit is 20MB,file format jpg,png,gif,jpeg,bmp,pdf,mp3,mp4,doc,docx,csv,xls,xlsx,ppt,pptx,zip,7z,rar,tar)

Click or drag file to upload